Symphony Evolution, Inc.
11Patents
8Active
11Granted
41Portfolio score
Filing activity: Jun 11, 2003 → Aug 31, 2017 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7626031B2 | Substituted 3-(diarylmethylene)indolin-2-ones and methods of their use | Chemistry; Metallurgy | 5 | Expired |
| US7629341B2 | Human ADAM-10 inhibitors | Chemistry; Metallurgy | 1 | Expired |
| US7989661B2 | Human ADAM-10 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8658654B2 | Receptor-type kinase modulators and methods of use | Chemistry; Metallurgy | 1 | Active |
| US9956221B2 | Use of a receptor-type kinase modulator for treating polycystic kidney disease | Human Necessities | 0 | Active |
| US9359332B2 | Processes for the preparation of substituted quinazolines | Chemistry; Metallurgy | 0 | Active |
| US9163006B2 | Processes for the preparation of substituted quinazolines | General | 0 | Revoked |
| US8426415B2 | Human ADAM-10 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9364479B2 | Use of a receptor-type kinase modulator for treating polycystic kidney disease | Human Necessities | 0 | Active |
| US9796704B2 | Substituted quinazolines as receptor-type kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10266518B2 | Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.